Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Fortrea Holdings Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
FTRE
Nasdaq
8731
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Fortrea Holdings Inc
Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call
- Apr 11th, 2024 11:00 am
Fortrea Holdings Full Year 2023 Earnings: EPS Misses Expectations
- Mar 12th, 2024 6:59 pm
Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
- Mar 11th, 2024 10:30 am
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
- Mar 11th, 2024 10:30 am
With A 3.9% Return On Equity, Is Fortrea Holdings Inc. (NASDAQ:FTRE) A Quality Stock?
- Feb 23rd, 2024 1:12 pm
Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion
- Feb 20th, 2024 9:05 pm
Fortrea to Present at the Barclays 26th Annual Global Healthcare Conference
- Feb 20th, 2024 12:00 pm
Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference Call
- Jan 29th, 2024 12:00 pm
Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clinical Trial Experience
- Jan 9th, 2024 9:22 pm
Fortrea Previews J.P. Morgan Healthcare Conference Updates
- Jan 8th, 2024 12:00 pm
FORTREA SELECTS COGNIZANT AS ITS TECHNOLOGY TRANSFORMATION PROVIDER
- Jan 4th, 2024 1:00 pm
Fortrea to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 2nd, 2024 12:00 pm
Fortrea Convenes New Site Advisory Board
- Dec 13th, 2023 12:00 pm
Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials
- Nov 20th, 2023 12:00 pm
Fortrea Holdings Inc (FTRE) Reports Mixed Q3 Results Amidst Transformation
- Nov 13th, 2023 4:07 pm
Fortrea Reports Third Quarter 2023 Results
- Nov 13th, 2023 11:30 am
Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K.
- Nov 2nd, 2023 11:00 am
Starboard Value Issues Presentation Delivered at 13D Monitor’s 2023 Active-Passive Investor Summit
- Oct 17th, 2023 1:05 pm
Fortrea Appoints Life Science Executive Dr. John Doyle to Lead Consulting Team
- Oct 13th, 2023 11:00 am
Fortrea Announces Date for Third Quarter 2023 Financial Results and Conference Call
- Oct 11th, 2023 11:00 am
Scroll